Transplantation · 1992 · 100 citations · 0 references
MedicineNephrologyPharmacologyRenal PathologyRenal PathophysiologyRenal PharmacotherapyNephrotoxicity MechanismsRenal DiseaseRenal Drug ClearanceRenal Function TestsRenal PharmacologyRenal ToxicityAnimal Weight GainBody Weight RegulationImmunosuppressive CompoundsImpaired Kidney FunctionNephrotoxic MedicationsProximal Tubule DamageProximal Tubule PhysiologyRenal Drugs
The effects of rapamycin (RAPA) on kidney function and histology were investigated in the Sprague-Dawley rat and compared with cyclosporine. Drugs were administered orally in a Cremophor-ethanol formulation for 14 days in two separate studies. RAPA, at 1 mg/kg, had no effect either functionally or histologically on the kidney. At 10 mg/kg, RAPA depressed the gain in body weight by 20% in the rat but had only minor functional disturbances on urine output, plasma creatinine, and creatinine clearance in the kidney. It did not induce any histomorphologic abnormalities. CsA, at 25 mg/kg, produced functional alterations in the kidney including elevated plasma creatinine and depressed clearance of creatinine as well as depressed body weight gain (17%). Histologically, CsA induced proximal tubule damage. These results demonstrate that RAPA (10 mg/kg) does not produce nephrotoxicity in the Sprague-Dawley rat at doses three times higher than its effective immunosuppressive doses established in the rat.